From market research to funding, today, we will dismantle the top 5 reasons for startup failure. At HEMEX, we have seen many cases in our years of experience in this field. For this reason, we hope to give you some hints to look out for while navigating the ever-changing startup ecosystem.
23
Mar
Mar
Increasing patients’ safety and care in research is vital when preparing and conducting your study. From a HEMEX perspective, we are tackling in this article four important points you should consider during the process.
19
Jan
Jan
Eating healthier, regular exercise, or reading more books – many people use the New Year to tackle new projects or follow through on old plans. What’s on your list of New Year’s resolutions for 2022?
11
Jan
Jan
Apply by January 16 to the Venture Leaders Technology program, where you’ll meet industry leaders and top technology investors in Silicon Valley
06
Dec
Dec
The Austrian biotech company is developing endolysins and phages as therapeutics, focusing on persistent bacterial infections that cannot be targeted with broad-spectrum antibiotics. This acquisition is a big step for the AMR crisis and the formerly Phagomed team. At HEMEX, we wanted to congratulate them on their fantastic job!
Diversity, Funding, Gender, Pitch Deck
2nd Diversity Series: Meet the great people and minds behind HEMEX’s success!
01
Oct
Oct
Unique cultures, different opportunities, and many smiles: Meet the team working towards a common goal!
Diversity, Funding, Gender, Pitch Deck
How can we make the Informed Consent Form process more patient-friendly?
01
Sep
Sep
Complicated words and sentences may be misunderstood and are very often unfamiliar to the patients. This led us to discuss how we could find the optimal solution for all parties involved in a clinical study: the patient, physician, and sponsor/CRO.
15
Jul
Jul
Every Start-up knows the importance of a great pitch. Today we want to give you some advice on how to find out the essential ingredients to bake a delicious pitch which investors will enjoy every single bite. More importantly, leave them craving for more!
20
May
May
Inura Medical’s mission is to improve women’s health through the development of an urethral ovulum for the treatment of patients suffering from urinary bladder diseases. Their first pharmaceutical product is addressing an unmet medical need in overactive bladder (OAB).
06
May
May
HexagonFab, a spin-out from the University of Cambridge, has developed a novel approach for drug discovery and production process monitoring called the Bolt. This innovative device is an analytical lab instrument that provides convenient and affordable access to molecular binding analytics.